2Dechend R,Fiebeler A, Park J K, et a l . Amelioration of angiotensin Ⅱ-induced injury by a 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitor[J]. Circulation , 2001, 104: 576-581.
3Coelho-Filho OR, De Luca IMS, Tanus-Santos JE, et al.Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats[J]. Int J Cardiol ,2001,79:215-221.
4Olsson M,Thyberg J ,Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves[J]. VTVB,1999,1218-1222.
5Rajamanan WU,Subramanian M,Soringett M, et al . Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve[J].Circulation ,2001,103 : 1522-1528.
6Shavelle DM, Takasu J, Budoff MJ, et al . HMG-CoA reductase inhibitor(statin) and aortic valve calcium[J]. Lancet , 2002,360:1125-1126.
7Novaro GM,Tiong IY,Pearce GL, et al . Effect of hydroxymethyglutaryl coenzyme, a reductase inhibitors on the progression of calcific aortic stenosis[J]. Circulation , 2001,104 : 2205-2220.
8De Lorgeril M, Salen P, Bontemps L, et al . Effects of lipid-lowering drugs on left ventricular function and exercise tolerance indyslipidemic coronary patients[J]. J Cardiovasc Pharmacol ,1999,33 : 473-478.
9Node K. Short-term statin therapy improves cardiac function and symptons in patients with idiopathic dilated cardiomyopathy[J]. Circulation , 2003,108:839-843.
10Mitchell LB, Powell JL,Gillis AM, et al . Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the antiarrhythmics versus implantable defibrillators(AVID) trial[J].J Am Coll Cardiol ,2003,42:81-87.
